HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Industrial Cannabis/Industrial Hemp

660.129

-5.583-0.84%

Number of Gainers:1

Number of Losers:3

Number of Flat:3

PE:- -

High:667.110

Open:661.116

Low:657.186

Close:665.712

Volume:40.58M

Turnover:59.67M

Market Cap:26.30B

Float Cap:26.30B

Loading ...

MEILLEURE HEALTH (02327) Shareholder Transfers Shares from CITIC SEC to Minsheng Bank Securities, Valued at HK$68.76 Million

LIFETECH SCI (01302): G-BranchTM Thoracoabdominal Aortic Stent Graft System Receives Official Registration Approval from NMPA

LifeTech Scientific Wins China NMPA Approval for G-Branch Thoracoabdominal Artery Stent Graft System

LifeTech Scientific - G-Branch Thoracoabdominal Artery Stent Graft System Approved by China Nmpa

THOMSON REUTERS

China Carbon Neutral Development Group Extends Deadline for HK$77.3 Million Convertible Bond Issuance

SIHUAN PHARM Surges Over 4% in Early Trading After Signing Collaboration Agreement with U.S.'s AbaloneBio

BRIEF-Sihuan Pharma Signs Agreement With Abalone Bio

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":660.12885,"timestamp":1763102128153,"preClose":665.71204,"halted":0,"volume":40583000,"delay":0,"changeRate":-0.008387,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-5.583191,"latestTime":"11-14 14:36:38","open":661.11646,"high":667.11,"low":657.1855,"amount":59667143,"amplitude":0.014908,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"pbRate":2.265101,"peRate":402.310954,"turnoverRate":0.001452,"increases":1,"decrements":3,"flats":3,"marketCap":26298514144,"floatMarketCap":26298446048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":667.11,"amplitude":0.014908,"preClose":665.71204,"low":657.1855,"pbRate":"2.265101","latestPrice":660.12885,"volume":40583000,"delay":0,"open":661.11646,"prevYearClose":390.2235,"prevWeekClose":650.911,"prevMonthClose":679.721,"prevQuarterClose":696.976,"fiveDayClose":650.911,"twentyDayClose":698.986,"sixtyDayClose":720.144,"secType":"PLATE","market":"HK","turnoverRate":0.001452,"peRate":402.310954,"marketCap":26298514144,"floatMarketCap":26298446048,"timestamp":1763102128153,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":1,"down":3,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191736261","title":"MEILLEURE HEALTH (02327) Shareholder Transfers Shares from CITIC SEC to Minsheng Bank Securities, Valued at HK$68.76 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1191736261","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191736261?lang=en_us&edition=fundamental","pubTime":"2025-11-07 08:36","pubTimestamp":1762475782,"startTime":"0","endTime":"0","summary":"On November 6, a shareholder of MEILLEURE HEALTH (02327) transferred shares from CITIC SEC Hong Kong to Minsheng Bank Securities, with a transfer value of HK$68.76 million, accounting for 6.11% of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","LU2495084118.USD","BK0188","LU0405327494.USD","LU0405327148.USD","BK0028","LU1064130708.USD","BK0012","BK1516","LU1328615791.USD","LU1655091616.SGD","LU2289578879.USD","BK1521","LU2148510915.USD","BK0183","LU1997245177.USD","161027","02327","BK1124","BK1600","LU1064131003.USD","BK0196","600030","BK1564","LU1255011170.USD","BK1147","LU1997244956.HKD","06030","LU1997245094.SGD","BK0276","LU1794554557.SGD"],"gpt_icon":0},{"id":"1192583551","title":"LIFETECH SCI (01302): G-BranchTM Thoracoabdominal Aortic Stent Graft System Receives Official Registration Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1192583551","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192583551?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434019,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) announced that on November 6, 2025, the G-BranchTM Thoracoabdominal Aortic Stent Graft System (G-BranchTM or the Product), jointly developed by Professor Guo Wei's team from the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1100","BK1600","BK1583"],"gpt_icon":0},{"id":"2581709892","title":"LifeTech Scientific Wins China NMPA Approval for G-Branch Thoracoabdominal Artery Stent Graft System","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709892?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:50","pubTimestamp":1762433436,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation has announced that its G-Branch Thoracoabdominal Artery Stent Graft System has received official registration approval from the China National Medical Products Administration . This approval follows the earlier launch of the company's Aortic Arch Stent Graft System and Aortic Stent Graft System in the first half of 2025, further expanding LifeTech's portfolio in peripheral vascular intervention. With this milestone, LifeTech becomes one of the first innovative companies to offer integrated endovascular aortic repair solutions globally. The company plans to continue advancing and commercializing new medical device products to address urgent clinical needs. No grant or funding from multiple organizations was mentioned in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL5dyFKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1583","BK1600","BK1100"],"gpt_icon":0},{"id":"2581209866","title":"LifeTech Scientific - G-Branch Thoracoabdominal Artery Stent Graft System Approved by China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2581209866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581209866?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:46","pubTimestamp":1762433215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI1PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","01302","BK1583","BK1600"],"gpt_icon":0},{"id":"2579555414","title":"China Carbon Neutral Development Group Extends Deadline for HK$77.3 Million Convertible Bond Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579555414","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579555414?lang=en_us&edition=fundamental","pubTime":"2025-10-31 16:46","pubTimestamp":1761900363,"startTime":"0","endTime":"0","summary":"China Carbon Neutral Development Group Ltd. has announced an update regarding its proposed issuance of convertible bonds under a specific mandate, as previously disclosed in its 30 May 2025 announcement. The convertible bonds will be issued to offset indebtedness acquired by the Subscribers, Green Assets and Green Securities, who purchased debts from the Company's original creditors in the aggregate principal amounts of approximately HK$47.5 million and HK$29.8 million, respectively. The issuance is considered a connected transaction under the Hong Kong Listing Rules due to the involvement of connected persons. The company has extended the long stop date for the completion of the subscription agreements to 31 October 2025 to allow more time for fulfilling the conditions precedent. Completion of the subscription remains subject to these conditions being satisfied or waived. No specific details on the price, maturity date, or interest rate of the convertible bonds were disclosed in the a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL4gBn4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1144","BK1594","01372","BK1148"],"gpt_icon":0},{"id":"1158632927","title":"SIHUAN PHARM Surges Over 4% in Early Trading After Signing Collaboration Agreement with U.S.'s AbaloneBio","url":"https://stock-news.laohu8.com/highlight/detail?id=1158632927","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158632927?lang=en_us&edition=fundamental","pubTime":"2025-10-30 11:20","pubTimestamp":1761794439,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) rose more than 4% in early trading, with shares up 4.11% to HKD 1.52 at the time of writing, recording a turnover of HKD 57.79 million. On October 30, SIHUAN PHARM announced that...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1515","BK1191","BK1600","BK1593"],"gpt_icon":0},{"id":"2579152824","title":"BRIEF-Sihuan Pharma Signs Agreement With Abalone Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2579152824","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579152824?lang=en_us&edition=fundamental","pubTime":"2025-10-30 09:20","pubTimestamp":1761787251,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Signs Agreement With Abalone BioOct 30 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:SIGNS AGREEMENT WITH ABALONE BIOCO AND ABALONE TO DEVELOP NEW OBESITY DRUGFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WA2HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK1600","BK1593","00460"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}